Dewpoint Therapeutics granted second breakthrough condensates platform technology patent by US Patent Office
BOSTON, Nov. 14, 2022 — Dewpoint Therapeutics Inc. today announced the U.S. Patent and Trademark Office (USPTO) issued the patent “Methods of Characterizing […]